Patients contributing to Australia's HTA processes are forced to use an online portal, do not know how their input is used, and receive no follow-up or feedback. Compare that to the role of patient input under the US government's price negotiation power for prescription medicines. …
US price negotiation power reveals a very different approach to patient input
March 20, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
The need to honour a strong history while ensuring the future is guided by the 'good guys'
November 17, 2025 - - Latest News -
BMS Australia team cycles across Japan, raising nearly $20,000 for Bowel Cancer Australia
November 17, 2025 - - Latest News -
Syntara secures positive European opinion for orphan designation of amsulostat in myelofibrosis
November 17, 2025 - - Australian Biotech -
Mesoblast appoints Chief Financial Officer as it evolves into fully integrated commercial organisation
November 17, 2025 - - Australian Biotech -
Argent BioPharma secures significant financing facility to support strategic expansion
November 17, 2025 - - Australian Biotech -
Race Oncology launches new clinical programs in AML and lung cancer
November 17, 2025 - - Australian Biotech -
Noxopharm begins daily dosing in second phase of HERACLES trial
November 17, 2025 - - Australian Biotech